Managing high-risk pulmonary embolism
Systemic thrombolysis, specifically using recombinant tissue plasminogen activator (rtPA), is the current gold standard treatment for high-risk pulmonary embolism (PE). […]
Systemic thrombolysis, specifically using recombinant tissue plasminogen activator (rtPA), is the current gold standard treatment for high-risk pulmonary embolism (PE). […]
Stroke is a devastating complication of both coronary artery bypass grafting (CABG) surgery and percutaneous coronary intervention (PCI). In a […]